Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of AMG 691 in Healthy Chinese and Japanese Participants
NCT07745907Phase 1Recruiting
- Sponsor
- Amgen
- Start
- Aug 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of AMG 691 (4 cohorts), sponsored by Amgen. Primary endpoints: Maximum Observed Serum Concentration, Area Under the Serum Concentration Time Curve from Time Zero to Time of Last Quantifiable Concentration and 1 more. Started Aug 2026; status: recruiting.
02
Drugs
AMG 691
Beyond the preview
Go deeper on NCT07745907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07745907.